Botanix Pharmaceuticals Limited (BOT.AX)
AUD 0.42
(1.22%)
AUD 0.42
(1.22%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -14.69 Million AUD | -14.88% |
| 2023 | -12.79 Million AUD | 19.73% |
| 2022 | -15.94 Million AUD | -55.26% |
| 2021 | -10.26 Million AUD | 57.68% |
| 2020 | -24.25 Million AUD | -11.05% |
| 2019 | -21.84 Million AUD | -68.81% |
| 2018 | -12.94 Million AUD | -169.25% |
| 2017 | -4.8 Million AUD | -197.51% |
| 2016 | -1.61 Million AUD | -190.87% |
| 2015 | -555.37 Thousand AUD | 75.53% |
| 2014 | -2.27 Million AUD | -36.44% |
| 2013 | -1.66 Million AUD | -11.62% |
| 2012 | -1.49 Million AUD | 1.93% |
| 2011 | -1.51 Million AUD | 23.59% |
| 2010 | -1.98 Million AUD | 37.01% |
| 2009 | -3.15 Million AUD | 0.45% |
| 2008 | -3.17 Million AUD | 14.65% |
| 2007 | -3.71 Million AUD | -16.76% |
| 2006 | -3.18 Million AUD | 1.77% |
| 2005 | -3.24 Million AUD | -232.41% |
| 2004 | -974.99 Thousand AUD | 34.95% |
| 2003 | -1.49 Million AUD | -139.83% |
| 2002 | -624.99 Thousand AUD | -41.4% |
| 2001 | -441.99 Thousand AUD | 87.05% |
| 2000 | -3.41 Million AUD | 56.72% |
| 1999 | -7.88 Million AUD | 51.95% |
| 1998 | -16.41 Million AUD | -140.5% |
| 1997 | 40.52 Million AUD | 41.24% |
| 1996 | 28.69 Million AUD | -51.42% |
| 1995 | 59.06 Million AUD | 52.89% |
| 1994 | 38.63 Million AUD | 38.16% |
| 1993 | 27.96 Million AUD | 21.85% |
| 1992 | 22.94 Million AUD | 2.13% |
| 1991 | 22.46 Million AUD | 24.2% |
| 1990 | 18.09 Million AUD | 11.94% |
| 1989 | 16.16 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | -8.83 Million AUD | 0.0% |
| 2024 FY | -15.45 Million AUD | -20.82% |
| 2024 Q2 | -5.52 Million AUD | 0.0% |
| 2023 Q2 | -8.28 Million AUD | 0.0% |
| 2023 FY | -12.79 Million AUD | 19.73% |
| 2023 Q4 | -4.51 Million AUD | 0.0% |
| 2022 Q2 | -6.52 Million AUD | 0.0% |
| 2022 FY | -15.94 Million AUD | -55.26% |
| 2022 Q4 | -9.41 Million AUD | 0.0% |
| 2021 Q4 | -4 Million AUD | 0.0% |
| 2021 FY | -10.26 Million AUD | 57.68% |
| 2021 Q2 | -6.26 Million AUD | 0.0% |
| 2020 Q2 | -14.51 Million AUD | 0.0% |
| 2020 Q4 | -9.74 Million AUD | 0.0% |
| 2020 FY | -24.25 Million AUD | -11.05% |
| 2019 Q4 | -12.92 Million AUD | 0.0% |
| 2019 FY | -21.84 Million AUD | -68.81% |
| 2019 Q2 | -4.25 Million AUD | 0.0% |
| 2018 FY | -12.94 Million AUD | -169.25% |
| 2018 Q2 | -2.41 Million AUD | 0.0% |
| 2018 Q4 | -8.74 Million AUD | 0.0% |
| 2017 Q4 | -3.56 Million AUD | 0.0% |
| 2017 Q2 | -1.23 Million AUD | 0.0% |
| 2017 FY | -4.8 Million AUD | -197.51% |
| 2016 Q1 | -138.84 Thousand AUD | 0.0% |
| 2016 Q2 | -163.57 Thousand AUD | -17.81% |
| 2016 Q4 | -172.86 Thousand AUD | 57.2% |
| 2016 FY | -1.61 Million AUD | -190.87% |
| 2016 Q3 | -403.86 Thousand AUD | -146.9% |
| 2015 Q2 | -138.84 Thousand AUD | 75.53% |
| 2015 Q3 | -138.84 Thousand AUD | 0.0% |
| 2015 FY | -555.37 Thousand AUD | 75.53% |
| 2015 Q4 | - AUD | 100.0% |
| 2015 Q1 | -567.51 Thousand AUD | 0.0% |
| 2014 Q2 | -567.51 Thousand AUD | -36.44% |
| 2014 Q3 | -567.51 Thousand AUD | 0.0% |
| 2014 Q1 | -415.94 Thousand AUD | 0.0% |
| 2014 Q4 | - AUD | 100.0% |
| 2014 FY | -2.27 Million AUD | -36.44% |
| 2013 Q1 | -372.64 Thousand AUD | 0.0% |
| 2013 Q3 | -415.94 Thousand AUD | 0.0% |
| 2013 FY | -1.66 Million AUD | -11.62% |
| 2013 Q2 | -415.94 Thousand AUD | -11.62% |
| 2013 Q4 | - AUD | 100.0% |
| 2012 Q4 | - AUD | 100.0% |
| 2012 Q2 | -372.64 Thousand AUD | 1.93% |
| 2012 Q3 | -372.64 Thousand AUD | 0.0% |
| 2012 Q1 | -379.97 Thousand AUD | 0.0% |
| 2012 FY | -1.49 Million AUD | 1.93% |
| 2011 FY | -1.51 Million AUD | 23.59% |
| 2011 Q3 | -379.97 Thousand AUD | 0.0% |
| 2011 Q2 | -379.97 Thousand AUD | 23.59% |
| 2011 Q1 | -497.29 Thousand AUD | 0.0% |
| 2011 Q4 | - AUD | 100.0% |
| 2010 FY | -1.98 Million AUD | 37.01% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 Q3 | -497.29 Thousand AUD | 0.0% |
| 2010 Q2 | -497.29 Thousand AUD | 37.01% |
| 2010 Q1 | -789.53 Thousand AUD | 0.0% |
| 2009 FY | -3.15 Million AUD | 0.45% |
| 2009 Q1 | -793.12 Thousand AUD | 0.0% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 Q3 | -789.53 Thousand AUD | 0.0% |
| 2009 Q2 | -789.53 Thousand AUD | 0.45% |
| 2008 FY | -3.17 Million AUD | 14.65% |
| 2008 Q4 | - AUD | 100.0% |
| 2008 Q3 | -793.12 Thousand AUD | 0.0% |
| 2008 Q2 | -793.12 Thousand AUD | 14.65% |
| 2008 Q1 | -929.21 Thousand AUD | 0.0% |
| 2007 Q3 | -929.21 Thousand AUD | 0.0% |
| 2007 Q4 | - AUD | 100.0% |
| 2007 Q2 | -929.21 Thousand AUD | -16.76% |
| 2007 Q1 | -795.86 Thousand AUD | 0.0% |
| 2007 FY | -3.71 Million AUD | -16.76% |
| 2006 FY | -3.18 Million AUD | 1.77% |
| 2006 Q3 | -795.86 Thousand AUD | 0.0% |
| 2006 Q4 | - AUD | 100.0% |
| 2006 Q2 | -795.86 Thousand AUD | 1.77% |
| 2006 Q1 | -810.23 Thousand AUD | 0.0% |
| 2005 Q2 | -810.23 Thousand AUD | -232.41% |
| 2005 FY | -3.24 Million AUD | -232.41% |
| 2005 Q1 | -243.74 Thousand AUD | 0.0% |
| 2005 Q4 | - AUD | 100.0% |
| 2005 Q3 | -810.23 Thousand AUD | 0.0% |
| 2004 Q4 | - AUD | 100.0% |
| 2004 Q2 | -243.74 Thousand AUD | 34.95% |
| 2004 Q1 | -374.73 Thousand AUD | 0.0% |
| 2004 FY | -974.99 Thousand AUD | 34.95% |
| 2004 Q3 | -243.74 Thousand AUD | 0.0% |
| 2003 FY | -1.49 Million AUD | -139.83% |
| 2003 Q3 | -374.73 Thousand AUD | 0.0% |
| 2003 Q1 | -156.24 Thousand AUD | 0.0% |
| 2003 Q4 | - AUD | 100.0% |
| 2003 Q2 | -374.73 Thousand AUD | -139.83% |
| 2002 Q2 | -156.24 Thousand AUD | -41.4% |
| 2002 Q4 | - AUD | 100.0% |
| 2002 FY | -624.99 Thousand AUD | -41.4% |
| 2002 Q3 | -156.24 Thousand AUD | 0.0% |
| 2002 Q1 | -110.49 Thousand AUD | 0.0% |
| 2001 Q3 | -110.49 Thousand AUD | 0.0% |
| 2001 Q2 | -110.49 Thousand AUD | 93.29% |
| 2001 Q4 | - AUD | 100.0% |
| 2001 Q1 | -1.64 Million AUD | 0.0% |
| 2001 FY | -441.99 Thousand AUD | 87.05% |
| 2000 Q2 | -1.64 Million AUD | 17.4% |
| 2000 FY | -3.41 Million AUD | 56.72% |
| 2000 Q4 | - AUD | 100.0% |
| 2000 Q3 | -1.64 Million AUD | 0.0% |
| 2000 Q1 | -1.99 Million AUD | 0.0% |
| 1999 Q1 | -4.08 Million AUD | 0.0% |
| 1999 Q4 | - AUD | 100.0% |
| 1999 FY | -7.88 Million AUD | 51.95% |
| 1999 Q2 | -1.99 Million AUD | 51.18% |
| 1999 Q3 | -1.99 Million AUD | 0.0% |
| 1998 FY | -16.41 Million AUD | -140.5% |
| 1998 Q1 | 10.13 Million AUD | 0.0% |
| 1998 Q3 | -4.08 Million AUD | 0.0% |
| 1998 Q2 | -4.08 Million AUD | -140.3% |
| 1998 Q4 | -4.08 Million AUD | 0.0% |
| 1997 Q4 | - AUD | -100.0% |
| 1997 FY | 40.52 Million AUD | 41.24% |
| 1997 Q1 | 7.17 Million AUD | 0.0% |
| 1997 Q2 | 10.13 Million AUD | 41.24% |
| 1997 Q3 | 10.13 Million AUD | 0.0% |
| 1996 Q2 | 7.17 Million AUD | -51.42% |
| 1996 Q4 | 7.17 Million AUD | 0.0% |
| 1996 FY | 28.69 Million AUD | -51.42% |
| 1996 Q1 | 14.76 Million AUD | 0.0% |
| 1996 Q3 | 7.17 Million AUD | 0.0% |
| 1995 FY | 59.06 Million AUD | 52.89% |
| 1995 Q1 | 9.65 Million AUD | 0.0% |
| 1995 Q4 | 14.76 Million AUD | 0.0% |
| 1995 Q3 | 14.76 Million AUD | 0.0% |
| 1995 Q2 | 14.76 Million AUD | 52.89% |
| 1994 Q2 | 9.65 Million AUD | 38.16% |
| 1994 FY | 38.63 Million AUD | 38.16% |
| 1994 Q4 | 9.65 Million AUD | 0.0% |
| 1994 Q3 | 9.65 Million AUD | 0.0% |
| 1994 Q1 | 6.99 Million AUD | 0.0% |
| 1993 Q1 | 5.73 Million AUD | 0.0% |
| 1993 FY | 27.96 Million AUD | 21.85% |
| 1993 Q4 | 6.99 Million AUD | 0.0% |
| 1993 Q3 | 6.99 Million AUD | 0.0% |
| 1993 Q2 | 6.99 Million AUD | 21.85% |
| 1992 Q2 | 5.73 Million AUD | 2.13% |
| 1992 Q1 | 5.61 Million AUD | 0.0% |
| 1992 Q3 | 5.73 Million AUD | 0.0% |
| 1992 FY | 22.94 Million AUD | 2.13% |
| 1992 Q4 | 5.73 Million AUD | 0.0% |
| 1991 Q4 | 5.61 Million AUD | 0.0% |
| 1991 FY | 22.46 Million AUD | 24.2% |
| 1991 Q1 | 4.52 Million AUD | 0.0% |
| 1991 Q2 | 5.61 Million AUD | 24.2% |
| 1991 Q3 | 5.61 Million AUD | 0.0% |
| 1990 Q1 | 4.04 Million AUD | 0.0% |
| 1990 Q2 | 4.52 Million AUD | 11.94% |
| 1990 FY | 18.09 Million AUD | 11.94% |
| 1990 Q3 | 4.52 Million AUD | 0.0% |
| 1990 Q4 | 4.52 Million AUD | 0.0% |
| 1989 Q3 | 4.04 Million AUD | 0.0% |
| 1989 FY | 16.16 Million AUD | 0.0% |
| 1989 Q4 | 4.04 Million AUD | 0.0% |
| 1989 Q2 | 4.04 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Memphasys Limited | -2.7 Million AUD | -443.634% |
| Race Oncology Limited | -13.38 Million AUD | -9.86% |
| AdAlta Limited | -5.26 Million AUD | -179.38% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -907.442% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -380.001% |
| BTC Health Limited | 1.05 Million AUD | 1492.973% |
| CSL Limited | 5.64 Billion AUD | 100.26% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 67.188% |
| Cynata Therapeutics Limited | -8.8 Million AUD | -66.894% |
| Imugene Limited | -140.93 Million AUD | 89.569% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -614.779% |
| PharmAust Limited | -6.65 Million AUD | -120.764% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | -103.274% |
| Acrux Limited | -9.83 Million AUD | -49.48% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 129.909% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -411.516% |
| Nyrada Inc. | -4.56 Million AUD | -222.342% |
| Orthocell Limited | -11.68 Million AUD | -25.843% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 68.863% |
| Starpharma Holdings Limited | -15.15 Million AUD | 3.029% |
| Zelira Therapeutics Limited | -5.93 Million AUD | -147.546% |
| Arovella Therapeutics Limited | -7.19 Million AUD | -104.362% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 25.007% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -232.202% |
| Biome Australia Limited | -1.91 Million AUD | -668.323% |
| Biotron Limited | -5.15 Million AUD | -185.369% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | -19.417% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 251.287% |
| Immutep Limited | -44.93 Million AUD | 67.288% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -588.961% |
| Noxopharm Limited | -7.53 Million AUD | -95.088% |
| Patrys Limited | -3.53 Million AUD | -315.35% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -104.551% |
| PYC Therapeutics Limited | -38.85 Million AUD | 62.17% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Dimerix Limited | -25.05 Million AUD | 41.341% |
| Hexima Limited | -1 Million AUD | -1357.235% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 106.505% |
| Nanollose Limited | -1.24 Million AUD | -1076.153% |
| Tissue Repair Ltd | -4.87 Million AUD | -201.477% |
| AnteoTech Limited | -11.72 Million AUD | -25.355% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 77.424% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 33.338% |
| Avecho Biotechnology Limited | -4.58 Million AUD | -220.315% |
| Actinogen Medical Limited | -12.83 Million AUD | -14.494% |
| Immuron Limited | -5.8 Million AUD | -153.397% |
| Argenica Therapeutics Limited | -5.67 Million AUD | -159.202% |